As­traZeneca and Avil­lion win ap­proval for new asth­ma res­cue treat­ment in adults

As­traZeneca and Avil­lion un­sur­pris­ing­ly pulled a win on Wednes­day for Air­supra in adults, months af­ter an FDA ad­vi­so­ry com­mit­tee vot­ed over­whelm­ing­ly in sup­port of the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER